Exozymes (EXOZ) Net Income (2023 - 2026)
Exozymes (EXOZ) posted quarterly Net Income of -$2.8 million for Q4 2025, down 356.17% year-over-year from $1.1 million in Q4 2024, and down 20.69% quarter-over-quarter from -$2.3 million in Q3 2025.
Exozymes (EXOZ) Net Income (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Net Income for 3 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Net Income fell 356.17% year-over-year to -$2.8 million; the TTM figure through Dec 2025 stood at -$9.3 million (down 100.07% YoY), while the FY2025 annual figure was -$9.2 million, down 97.79% from the prior year.
- Net Income eased to -$2.8 million in Q4 2025 per EXOZ's latest filing, from -$2.3 million in the prior quarter.
- Across five years, Net Income topped out at -$520596.0 in Q3 2023 and bottomed at -$2.8 million in Q4 2025.
- Historically, Net Income has averaged -$1.5 million across 3 years, with a median of -$1.5 million in 2024.
- Annual changes were most pronounced in 2024 — Net Income soared 42.72% — and 2025, when it sank 356.17%.
- Exozymes' Net Income stood at -$1.1 million in 2023, then surged by 42.72% to -$605094.0 in 2024, then plunged by 356.17% to -$2.8 million in 2025.
- Business Quant data shows EXOZ's Net Income at -$2.8 million in Q4 2025, -$2.3 million in Q3 2025, and -$2.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Exozymes | 62.35 Mn | 62.35 Mn | - | -2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.88 Mn |
| Dec 31, 2025 | -2.76 Mn |
| Sep 30, 2025 | -2.29 Mn |
| Jun 30, 2025 | -2.36 Mn |
| Mar 31, 2025 | -1.86 Mn |
| Dec 31, 2024 | -605,094.00 |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | -1.36 Mn |
| Mar 31, 2024 | -1.01 Mn |
| Dec 31, 2023 | -1.06 Mn |
| Sep 30, 2023 | -520,596.00 |